Total Funding
19
40
Total FundingPost-IPO Equity raised
Growth Score
-1 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
195329
StageZero Life Sciences is a biotech company developing and commercializing blood-based diagnostic tests for early disease detection.
- Choong-Chin Liew: Co-Founder and Chief Scientist
- Matthew J. Pietras: CFO & COO
About the Company
StageZero Life Sciences is a biotech company developing and commercializing blood-based diagnostic tests for early disease detection. The company next-generation test, Aristotle, is a multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle is built
on its proprietary mRNA technology platform, which was validated on 10,000 patients and used to develop the first liquid biopsy for Colorectal Cancer.
StageZero Life Sciences was founded in 1998 and is based in Richmond Hill, Ontario, Canada.
